Retatrutide: The Practical Guide
Reviewed against Phase 2 (NEJM 2023) and Phase 3 TRIUMPH data · Updated June 2026 What it actually does, the two reasons people use it, the real dosing debates, and the mistakes that wreck otherwise good protocols. Retatrutide is investigational. As of 2026 it is not FDA approved, with a filing expected in the 2026 […]
Tesamorelin: A Complete User’s Guide to the FDA-Approved GHRH Analog for Visceral Fat, Liver Fat, and Growth Hormone Optimization
Research-backed rationale for combining GHRH and GHRP peptides, including timing, dosing, and cycling protocols.
Glutathione: Dosage, Reconstitution, and an Honest Look at the Evidence
Breaking down the Phase 3 trial data on orforglipron and what it means for the future of GLP-1 research.
What is SS-31?
Research-backed rationale for ordering the mitochondrial peptide stack for maximum synergistic benefit.